HEADER APOPTOSIS 15-JUN-23 8T6F TITLE CRYSTAL STRUCTURE OF HUMAN MBP-MYELOID CELL LEUKEMIA 1 (MCL-1) IN TITLE 2 COMPLEX WITH BRD810 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MALTOSE/MALTODEXTRIN-BINDING PERIPLASMIC PROTEIN/INDUCED COMPND 3 MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL-1 CHIMERA; COMPND 4 CHAIN: A; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI K-12, HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 83333, 9606; SOURCE 5 GENE: MALE, B4034, JW3994, MCL1, BCL2L3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI O157:H7; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 83334 KEYWDS INHIBITOR, MCL1, MBP-FUSION, BRD810, APOPTOSIS EXPDTA X-RAY DIFFRACTION AUTHOR G.PONCET-MONTANGE,C.T.LEMKE REVDAT 1 19-JUN-24 8T6F 0 JRNL AUTH U.RAUH,G.WEI,M.SERRANO-WU,G.KOSMIDIS,S.KAULFUSS,F.SIEGEL, JRNL AUTH 2 K.THEDE,J.MCFARLAND,G.PONCET-MONTANGE,T.L.LEMKE,N.WERBECK, JRNL AUTH 3 K.NOWAK-REPPEL,S.PILARI,S.MENZ,M.OCKER,V.KAUSHIK,B.HUBBARD, JRNL AUTH 4 K.ZIEGELBAUER,T.R.GOLUB JRNL TITL BRD810 IS A NOVEL HIGHLY SELECTIVE MCL1 INHIBITOR WITH JRNL TITL 2 OPTIMIZED IN VIVO CLEARANCE AND ROBUST EFFICACY IN SOLID AND JRNL TITL 3 HEMATOLOGICAL TUMOR MODELS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.56 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.56 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 79.86 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 74453 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 3735 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 79.8600 - 4.6800 0.99 2849 157 0.1589 0.1616 REMARK 3 2 4.6800 - 3.7100 1.00 2725 148 0.1415 0.1852 REMARK 3 3 3.7100 - 3.2400 1.00 2703 114 0.1677 0.1933 REMARK 3 4 3.2400 - 2.9500 1.00 2646 153 0.1866 0.2107 REMARK 3 5 2.9500 - 2.7400 1.00 2622 155 0.1975 0.2237 REMARK 3 6 2.7400 - 2.5700 1.00 2670 130 0.1912 0.2414 REMARK 3 7 2.5700 - 2.4500 1.00 2641 145 0.1953 0.2440 REMARK 3 8 2.4500 - 2.3400 1.00 2637 141 0.2013 0.2102 REMARK 3 9 2.3400 - 2.2500 0.99 2583 142 0.1903 0.2175 REMARK 3 10 2.2500 - 2.1700 0.99 2639 148 0.1979 0.2559 REMARK 3 11 2.1700 - 2.1000 1.00 2596 137 0.2144 0.2374 REMARK 3 12 2.1000 - 2.0400 1.00 2625 132 0.2196 0.2291 REMARK 3 13 2.0400 - 1.9900 1.00 2598 144 0.2102 0.2481 REMARK 3 14 1.9900 - 1.9400 1.00 2624 127 0.2088 0.2474 REMARK 3 15 1.9400 - 1.9000 1.00 2601 129 0.2156 0.2649 REMARK 3 16 1.9000 - 1.8600 1.00 2600 142 0.2222 0.2479 REMARK 3 17 1.8600 - 1.8200 1.00 2564 134 0.2298 0.2801 REMARK 3 18 1.8200 - 1.7800 0.99 2655 119 0.2473 0.3165 REMARK 3 19 1.7800 - 1.7500 0.99 2587 142 0.2533 0.3188 REMARK 3 20 1.7500 - 1.7200 1.00 2577 126 0.2692 0.3381 REMARK 3 21 1.7200 - 1.7000 1.00 2586 151 0.2728 0.2950 REMARK 3 22 1.7000 - 1.6700 1.00 2561 128 0.2586 0.3005 REMARK 3 23 1.6700 - 1.6400 1.00 2630 125 0.2466 0.2831 REMARK 3 24 1.6400 - 1.6200 1.00 2593 138 0.2485 0.2910 REMARK 3 25 1.6200 - 1.6000 0.99 2547 123 0.2549 0.2590 REMARK 3 26 1.6000 - 1.5800 1.00 2577 174 0.0000 0.0000 REMARK 3 27 1.5800 - 1.5600 0.96 2482 131 0.2982 0.3441 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.200 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.540 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.74 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 NULL REMARK 3 ANGLE : 0.878 NULL REMARK 3 CHIRALITY : 0.053 638 REMARK 3 PLANARITY : 0.007 758 REMARK 3 DIHEDRAL : 5.476 618 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8T6F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-JUN-23. REMARK 100 THE DEPOSITION ID IS D_1000275337. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-OCT-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALBA REMARK 200 BEAMLINE : XALOC REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97903 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 74575 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.560 REMARK 200 RESOLUTION RANGE LOW (A) : 80.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 7.100 REMARK 200 R MERGE (I) : 0.03700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.56 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.66300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.27 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 3.75 MG/ML MBP-MCL1, 17.5 MM HEPES PH REMARK 280 7.5, 8% PEG 3350, 5% MPD, 5% DMSO, 2.5% PEG400, 75MM NACL, 25MM REMARK 280 MAGNESIUM FORMATE, 0.75MM DTT, 0.75 MM MALTOSE, 0.5MM ANJ810, REMARK 280 0.375% GLYCEROL, ~10-4 DILUTED MICROSEEDS, EQUILIBRATED AGAINST REMARK 280 1.5M NACL IN A EASYXTAL 15-WELL DROPGUARD CRYSTALLIZATION TOOL, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 49.15050 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 68.47850 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 49.15050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 68.47850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ASN A -23 CB CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A -28 -76.77 -82.43 REMARK 500 TYR A 87 -52.89 -120.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 401 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A-157 O REMARK 620 2 HOH A 654 O 91.5 REMARK 620 3 HOH A 728 O 90.0 97.7 REMARK 620 4 HOH A 795 O 87.1 91.5 170.5 REMARK 620 N 1 2 3 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4WGI RELATED DB: PDB DBREF 8T6F A -195 170 UNP P0AEX9 MALE_ECOLI 27 392 DBREF 8T6F A 174 321 UNP Q07820 MCL1_HUMAN 174 321 SEQADV 8T6F GLY A -196 UNP P0AEX9 EXPRESSION TAG SEQADV 8T6F GLY A 171 UNP P0AEX9 LINKER SEQADV 8T6F SER A 172 UNP P0AEX9 LINKER SEQADV 8T6F GLU A 173 UNP P0AEX9 LINKER SEQADV 8T6F ALA A 194 UNP Q07820 LYS 194 ENGINEERED MUTATION SEQADV 8T6F ALA A 197 UNP Q07820 LYS 197 ENGINEERED MUTATION SEQADV 8T6F ALA A 201 UNP Q07820 ARG 201 ENGINEERED MUTATION SEQRES 1 A 518 GLY LYS ILE GLU GLU GLY LYS LEU VAL ILE TRP ILE ASN SEQRES 2 A 518 GLY ASP LYS GLY TYR ASN GLY LEU ALA GLU VAL GLY LYS SEQRES 3 A 518 LYS PHE GLU LYS ASP THR GLY ILE LYS VAL THR VAL GLU SEQRES 4 A 518 HIS PRO ASP LYS LEU GLU GLU LYS PHE PRO GLN VAL ALA SEQRES 5 A 518 ALA THR GLY ASP GLY PRO ASP ILE ILE PHE TRP ALA HIS SEQRES 6 A 518 ASP ARG PHE GLY GLY TYR ALA GLN SER GLY LEU LEU ALA SEQRES 7 A 518 GLU ILE THR PRO ASP LYS ALA PHE GLN ASP LYS LEU TYR SEQRES 8 A 518 PRO PHE THR TRP ASP ALA VAL ARG TYR ASN GLY LYS LEU SEQRES 9 A 518 ILE ALA TYR PRO ILE ALA VAL GLU ALA LEU SER LEU ILE SEQRES 10 A 518 TYR ASN LYS ASP LEU LEU PRO ASN PRO PRO LYS THR TRP SEQRES 11 A 518 GLU GLU ILE PRO ALA LEU ASP LYS GLU LEU LYS ALA LYS SEQRES 12 A 518 GLY LYS SER ALA LEU MET PHE ASN LEU GLN GLU PRO TYR SEQRES 13 A 518 PHE THR TRP PRO LEU ILE ALA ALA ASP GLY GLY TYR ALA SEQRES 14 A 518 PHE LYS TYR GLU ASN GLY LYS TYR ASP ILE LYS ASP VAL SEQRES 15 A 518 GLY VAL ASP ASN ALA GLY ALA LYS ALA GLY LEU THR PHE SEQRES 16 A 518 LEU VAL ASP LEU ILE LYS ASN LYS HIS MET ASN ALA ASP SEQRES 17 A 518 THR ASP TYR SER ILE ALA GLU ALA ALA PHE ASN LYS GLY SEQRES 18 A 518 GLU THR ALA MET THR ILE ASN GLY PRO TRP ALA TRP SER SEQRES 19 A 518 ASN ILE ASP THR SER LYS VAL ASN TYR GLY VAL THR VAL SEQRES 20 A 518 LEU PRO THR PHE LYS GLY GLN PRO SER LYS PRO PHE VAL SEQRES 21 A 518 GLY VAL LEU SER ALA GLY ILE ASN ALA ALA SER PRO ASN SEQRES 22 A 518 LYS GLU LEU ALA LYS GLU PHE LEU GLU ASN TYR LEU LEU SEQRES 23 A 518 THR ASP GLU GLY LEU GLU ALA VAL ASN LYS ASP LYS PRO SEQRES 24 A 518 LEU GLY ALA VAL ALA LEU LYS SER TYR GLU GLU GLU LEU SEQRES 25 A 518 ALA LYS ASP PRO ARG ILE ALA ALA THR MET GLU ASN ALA SEQRES 26 A 518 GLN LYS GLY GLU ILE MET PRO ASN ILE PRO GLN MET SER SEQRES 27 A 518 ALA PHE TRP TYR ALA VAL ARG THR ALA VAL ILE ASN ALA SEQRES 28 A 518 ALA SER GLY ARG GLN THR VAL ASP GLU ALA LEU LYS ASP SEQRES 29 A 518 ALA GLN THR GLY SER GLU LEU TYR ARG GLN SER LEU GLU SEQRES 30 A 518 ILE ILE SER ARG TYR LEU ARG GLU GLN ALA THR GLY ALA SEQRES 31 A 518 ALA ASP THR ALA PRO MET GLY ALA SER GLY ALA THR SER SEQRES 32 A 518 ARG LYS ALA LEU GLU THR LEU ARG ARG VAL GLY ASP GLY SEQRES 33 A 518 VAL GLN ARG ASN HIS GLU THR ALA PHE GLN GLY MET LEU SEQRES 34 A 518 ARG LYS LEU ASP ILE LYS ASN GLU ASP ASP VAL LYS SER SEQRES 35 A 518 LEU SER ARG VAL MET ILE HIS VAL PHE SER ASP GLY VAL SEQRES 36 A 518 THR ASN TRP GLY ARG ILE VAL THR LEU ILE SER PHE GLY SEQRES 37 A 518 ALA PHE VAL ALA LYS HIS LEU LYS THR ILE ASN GLN GLU SEQRES 38 A 518 SER CYS ILE GLU PRO LEU ALA GLU SER ILE THR ASP VAL SEQRES 39 A 518 LEU VAL ARG THR LYS ARG ASP TRP LEU VAL LYS GLN ARG SEQRES 40 A 518 GLY TRP ASP GLY PHE VAL GLU PHE PHE HIS VAL HET GLC B 1 12 HET GLC B 2 11 HET MG A 401 1 HET YI7 A 402 50 HET DMS A 403 4 HET PGE A 404 10 HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM MG MAGNESIUM ION HETNAM YI7 (3AM,9S,15R)-4-CHLORO-3-ETHYL-7-{3-[(6- HETNAM 2 YI7 FLUORONAPHTHALEN-1-YL)OXY]PROPYL}-2-METHYL-15-[2- HETNAM 3 YI7 (MORPHOLIN-4-YL)ETHYL]-2,10,11,12,13,15- HETNAM 4 YI7 HEXAHYDROPYRAZOLO[4',3':9,10][1, HETNAM 5 YI7 6]OXAZACYCLOUNDECINO[8,7,6-HI]INDOLE-8-CARBOXYLIC ACID HETNAM DMS DIMETHYL SULFOXIDE HETNAM PGE TRIETHYLENE GLYCOL HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE FORMUL 2 GLC 2(C6 H12 O6) FORMUL 3 MG MG 2+ FORMUL 4 YI7 C39 H44 CL F N4 O5 FORMUL 5 DMS C2 H6 O S FORMUL 6 PGE C6 H14 O4 FORMUL 7 HOH *405(H2 O) HELIX 1 AA1 GLY A -180 GLY A -164 1 17 HELIX 2 AA2 LYS A -154 ALA A -144 1 11 HELIX 3 AA3 ARG A -130 SER A -123 1 8 HELIX 4 AA4 ASP A -114 ASP A -109 1 6 HELIX 5 AA5 TYR A -106 VAL A -99 1 8 HELIX 6 AA6 GLU A -65 ALA A -55 1 11 HELIX 7 AA7 GLU A -43 PHE A -40 5 4 HELIX 8 AA8 THR A -39 ASP A -32 1 8 HELIX 9 AA9 ASN A -11 ASN A 5 1 17 HELIX 10 AB1 ASP A 13 LYS A 23 1 11 HELIX 11 AB2 GLY A 32 TRP A 34 5 3 HELIX 12 AB3 ALA A 35 LYS A 43 1 9 HELIX 13 AB4 ASN A 76 TYR A 87 1 12 HELIX 14 AB5 THR A 90 LYS A 101 1 12 HELIX 15 AB6 LEU A 108 ALA A 116 1 9 HELIX 16 AB7 ASP A 118 GLY A 131 1 14 HELIX 17 AB8 GLN A 139 GLY A 157 1 19 HELIX 18 AB9 THR A 160 GLY A 192 1 33 HELIX 19 AC1 SER A 202 HIS A 224 1 23 HELIX 20 AC2 HIS A 224 LEU A 235 1 12 HELIX 21 AC3 ASN A 239 SER A 245 1 7 HELIX 22 AC4 SER A 245 SER A 255 1 11 HELIX 23 AC5 ASN A 260 ILE A 281 1 22 HELIX 24 AC6 GLN A 283 SER A 285 5 3 HELIX 25 AC7 CYS A 286 GLN A 309 1 24 HELIX 26 AC8 ARG A 310 PHE A 319 1 10 SHEET 1 AA1 6 VAL A-161 GLU A-158 0 SHEET 2 AA1 6 LEU A-189 TRP A-186 1 N ILE A-187 O GLU A-158 SHEET 3 AA1 6 ILE A-137 ALA A-133 1 O PHE A-135 N TRP A-186 SHEET 4 AA1 6 PHE A 62 ILE A 70 -1 O GLY A 69 N ILE A-136 SHEET 5 AA1 6 TYR A -90 GLU A -85 -1 N GLU A -85 O GLY A 64 SHEET 6 AA1 6 ALA A 105 VAL A 106 -1 O ALA A 105 N VAL A -86 SHEET 1 AA2 5 VAL A-161 GLU A-158 0 SHEET 2 AA2 5 LEU A-189 TRP A-186 1 N ILE A-187 O GLU A-158 SHEET 3 AA2 5 ILE A-137 ALA A-133 1 O PHE A-135 N TRP A-186 SHEET 4 AA2 5 PHE A 62 ILE A 70 -1 O GLY A 69 N ILE A-136 SHEET 5 AA2 5 GLU A 132 ILE A 133 1 O GLU A 132 N VAL A 63 SHEET 1 AA3 2 ARG A -98 TYR A -97 0 SHEET 2 AA3 2 LYS A -94 LEU A -93 -1 O LYS A -94 N TYR A -97 SHEET 1 AA4 4 SER A -51 LEU A -49 0 SHEET 2 AA4 4 THR A 26 ASN A 31 1 O ALA A 27 N SER A -51 SHEET 3 AA4 4 SER A -82 ASN A -78 -1 N ILE A -80 O THR A 29 SHEET 4 AA4 4 TYR A 46 THR A 49 -1 O THR A 49 N LEU A -81 SHEET 1 AA5 2 TYR A -29 TYR A -25 0 SHEET 2 AA5 2 TYR A -20 GLY A -14 -1 O ASP A -19 N LYS A -26 LINK O4 GLC B 1 C1 GLC B 2 1555 1555 1.43 LINK O HIS A-157 MG MG A 401 1555 1555 2.21 LINK MG MG A 401 O HOH A 654 1555 1555 1.99 LINK MG MG A 401 O HOH A 728 1555 1555 2.02 LINK MG MG A 401 O HOH A 795 1555 1555 2.17 CRYST1 98.301 136.957 38.257 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010173 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007302 0.000000 0.00000 SCALE3 0.000000 0.000000 0.026139 0.00000